STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal Transition

Aberrant expression of stanniocalcin 2 (STC2) is implicated in cancer development. STC2 acts as a tumor promoter to drive some cancers. However, its contribution to the development of pancreatic cancer remains unclear. This study showed that the expression of STC2 was significantly upregulated in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chen, Sun, Lina, Huang, Shenglei, Weng, Xiangqun, Wu, Zhixian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099867/
https://www.ncbi.nlm.nih.gov/pubmed/32258098
http://dx.doi.org/10.1155/2019/8042489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099867/
https://www.ncbi.nlm.nih.gov/pubmed/32258098
http://dx.doi.org/10.1155/2019/8042489

Ejemplares similares